Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;19(1):1329-1337.
doi: 10.4314/ahs.v19i1.4.

Review of Leishmaniasis in the Middle East and North Africa

Ahmed Tabbabi  1
Affiliations
Review

Review of Leishmaniasis in the Middle East and North Africa

Ahmed Tabbabi. Afr Health Sci. 2019 Mar.

Abstract

Background: Cutaneous and visceral forms of leishmaniasis are the most important protozoan infection in the Middle East and North Africa (MENA).

Objectives: Review the current knowledge on leishmaniasis in the MENA.

Methods: The data presented in this review are gathered primarily from WHO reports and from an extensive literature search on PubMed.

Results: There are four cycles of transmission of leishmaniasis: zoonotic cutaneous leishmaniasis (ZCL), induce by Leishmania (L.) major, transmitted by Phlebotomus (P.) papatasi, with rodent species of Psammomys obesus, Meriones libycus, Nesokia indica, and Rhombomys opimus are considered as host reservoirs. Zoonotic visceral leishmaniasis (ZVL) is inducing by L. infantum, transmitted by several Phlebotomus spp. of the sub-genus Larroussius and mainly P. perniciosus in more than one-half of the MENA countries and the dog species of Canis familiaris are considered as the main reservoirs. Anthroponotic cutaneous leishmaniasis (ACL), induce by L. tropica and transmitted by P. sergenti, without any non-human reservoir in most cases. Anthroponotic visceral leishmaniasis (AVL) induces by L. donovani spreads through P. alexandri, circulates exclusively in humans.

Conclusion: There are many challenges facing the successful control of leishmaniasis. However, there is continuing research into the treatment of leishmaniasis and potentially vaccinations for the disease.

Keywords: Cutaneous and visceral leishmaniasis; Middle East and North Africa; global distribution.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Map of the Middle East and North Africa region, by Adel Rhim
See this image and copyright information in PMC

References

    1. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infectious Diseases. 2007;7(9):581–596. doi: 10.1016/S1473-3099(07)70209-8. - DOI - PubMed
    1. Pearson RD, Sousa AQ. Clinical spectrum of Leishmaniasis. Clinical Infectious Diseases. 1996;22(1):1–13. doi: 10.1093/clinids/22.1.1. - DOI - PubMed
    1. Abbas K, Musatafa MA, Abass S, Kheir MM, Mukhtar M, et al. Mucosal leishmaniasis in a Sudanese patient. Am J Trop Med Hyg. 2009;80:935–938. https://www.ncbi.nlm.nih.gov/pubmed/?term=Abbas+K%2C+Musatafa+MA%2C+Abas.... - PubMed
    1. Elamin EM, Guizani I, Guerbouj S, Gramiccia M, El Hassan AM, et al. Identification of Leishmania donovani as a cause of cutaneous leishmaniasis in Sudan. Trans R Soc Trop Med Hyg. 2008;102:54–57. doi: 10.1016/j.trstmh.2007.10.005. - DOI - PubMed
    1. Khalil EA, Musa AM, Elgawi SH, Meshasha A, Gamar Eldawla I, et al. Revival of a focus of visceral leishmaniasis in central Sudan. Ann Trop Med Parasitol. 2008;102:79–80. doi: 10.1179/136485908X252269. - DOI - PubMed

MeSH terms